Venus Concept Corporation (VERO) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Venus Concept Inc. (VERO)

This price chart for Venus Concept Inc. (VERO) captures the indicator at 0.00. Production efficiency is declining due to underutilized capacity and debt. Management is currently conducting a deep restructuring of processes and sales optimization to return to profitability. Meanwhile, the business leads in the creation of non-invasive appearance correction systems, replacing surgical operations with affordable cosmetic procedures.

VERO Venus Concept Inc: Long-Term Debt to Equity in the range 07/04/2022 - 02/21/2026

Analytical breakdowns for Venus Concept Inc.

- share price and consensus valuation forecast:
Price Venus Concept Inc|VERO - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Venus Concept Inc.|VERO - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Venus Concept|VERO - Company Book Value|Market Value to Book Value venusconcept.com|VERO - Company Total Assets
- debt and solvency information:
Total Debt to Capital Venus Concept Inc.|VERO - Long-Term Debt to Equity|Current Liabilities to Equity venusconcept.com|VERO - Company Aggregate Debts|Debts to Book Value Venus Concept Inc.|VERO - Company Long-Term Liabilities|Company Short-Term Debts Venus Concept|Intermediate Liquidity Ratio venusconcept.com
- business earnings and investment ratios data:
VERO - Net Profit
Summary company analysis:VERO (Venus Concept Inc)
Core merchandise of Venus Concept Corporation

The indicator is calculated as the ratio of liabilities with a maturity of more than one year to equity. This metric determines the extent to which long-term financing depends on shareholders' funds, identifying risks of excessive leverage. For Venus Concept Inc. (VERO), the balance of borrowings is critical due to the dependence of equipment sales on consumer demand. Analyzing the long-term debt-to-equity ratio allows for an assessment of the company's resilience to revenue fluctuations. A low leverage level here serves as a guarantee of solvency.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital IINN|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Long-Term Debt to Capital IRIX (IRIDEX)|Long-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Long-Term Debt to Equity|PFSA: Long-Term Debt to Equity|SSKN (strataskinsciences.com) - Long-Term Debt to Equity Ratio|GlucoTrack Inc. - Long-Term Debt to Capital Coefficient|NAOV (NanoVibronix, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)